Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs

NCT03984318 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

1240

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

PROCEDURE: Blood sample

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris